Targeted dose CT lung cancer screening does not have substantial effect on life-years saved among high risk groups.
Compared to standard biopsy strategy, MR imaging-guided strategies are cost effective in helping detect prostate cancer.
Routine thyroid cancer screening among asymptomatic patients does not offer any benefit for patients.
Screening for breast cancer among women at average risk still varies considerably between physicians.
Female Medicare beneficiaries with early-stage cancers do participate in screening mammogram programs.
Screening mammography is not utilized equally among racial groups.
Patients who underwent low-dose CT for lung cancer screening and received false-positives benefited from counseling.
Cancer screening rates could go down if patients were made aware of the risk of overdiagnosis and overtreatment.